Cas No.: | 439085-51-5 |
Chemical Name: | 3-ethoxy-6-[2-[1-(6-methylpyridazin-3-yl)piperidin-4-yl]ethoxy]-1,2-benzoxazole |
Synonyms: | BTA798;BTA-798 |
SMILES: | CC1=NN=C(N2CCC(CCOC3=CC4ON=C(OCC)C=4C=C3)CC2)C=C1 |
Formula: | C21H26N4O3 |
M.Wt: | 382.464 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | Vapendavir (BTA798) is a novel potent enteroviral capsid binder, inhibits EV71 replication of all isolates with mean EC50 of 0.7 uM; efficiently inhibits the in vitro replication of 21 EV71 strains/isolates that are representative of the different genogroups A, B, and C; Vapendavir (BTA798) is currently under clinical study for the treatment of rhinovirus infections.Rhinovirus InfectionPhase 2 Clinical |